Facebook
Twitter
LinkedIn
Forward
2nd Annual Conference on Precision Psychiatry: Innovation to Implementation
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. Our Keynote Speakers will be Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022). The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022. The Conference is designed to cover a broad range of domains including:
- Applications of AI & machine learning in psychiatry
- Genomics and other omics
- Precision therapeutics
- Risk stratification for suicide and other important outcomes
- mHealth and digital technologies
- Implementation science
- Ethics and equity
Pricing
All Registrants: $200.00
Second Annual Conference on Precision Psychiatry Wednesday November 2, 2022 - Thursday, November 3, 2022 AGENDA
DAY ONE: Wednesday November 2, 2022 (1:00 PM - 5:30 PM EDT)
Time | Content | Speaker |
1:00pm-1:10pm | Welcome Remarks | JORDAN W. SMOLLER, MD, ScD & MAURIZIO FAVA, MD |
1:10pm-1:40pm | Conference Keynote: Presentation title TBD | THOMAS INSEL, MD Author of Healing: Our Path from Mental Illness to Mental Health; Former NIMH Director |
1:40pm-2:00pm | Moderated Discussion/Q&A: THOMAS INSEL, MD Moderator: JORDAN W. SMOLLER, MD | |
2:00pm-3:30pm | Leveraging Healthcare Data for Precision Medicine Session Chair: TBD | |
2:00pm-2:30pm | Presentation title TBD | LEA DAVIS, PhD Associate Professor Of Medicine, Vanderbilt University Medical Center |
2:30pm-3:00pm | Presentation title TBD | NIGAM SHAH, PhD Chief Data Scientist, Stanford Healthcare |
3:00pm-3:30pm | Moderated Discussion/Q&A: LEA DAVIS, PhD & NIGAM SHAH, PhD Moderator: TBD | |
3:30pm-3:50pm | BREAK | |
3:50pm-4:20pm | Data & Prediction: The Role of Academia and Industry in Advancing Precision Psychiatry Moderator: TBD | |
3:50pm-4:20pm | Panel | OLIVER HARRISON, MA, MPH Chief Executive Officer, Koa Health
SCOTT KOLLINS, PhD Chief Medical Officer, Holmusk |
4:20pm-5:20pm | Precision Treatment Stratification and Pharmacogenetics Session Chair: TBD | |
4:20pm-4:50pm | Presentation title TBD | CHAD BOUSMAN, PhD CEO/Founder, Sequence2Script; Associate Professor, University of Calgary |
4:50pm-5:20pm | Presentation title TBD | CATHRYN LEWIS, PhD Head of Department of Social, Genetic and Developmental Psychiatry Centre, King’s College London |
5:20pm-5:30pm | Closing Remarks | JORDAN W. SMOLLER, MD, ScD |
DAY TWO: Thursday, November 3, 2022 (9:00 AM - 2:00 PM EDT)
Time | Content | Speaker |
9:00am-9:10am | Welcome Remarks | JORDAN W. SMOLLER, MD, ScD |
9:10am-9:40am | Conference Keynote: Presentation title TBD | KELSEY MARTIN, MD, PhD Director of SFARI, Simons Foundation |
9:40am-10:00am | Moderated Discussion/Q&A: KELSEY MARTIN, MD, PhD Moderator: TBD | |
10:00am-11:00am | Methods and Tools Session Chair: TBD | |
10:00am-10:30am | Presentation title TBD | ANTHONY PHILIPPAKIS, MD, PhD Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV |
10:30am-11:00am | Presentation title TBD | LAURA GERMINE, PhD Director of Brain and Cognitive Health Technology, McLean Hospital; Assistant Professor, Harvard Medical School |
11:00am-12:00pm | Precision Neuroscience & Novel Therapeutics Session Chair: TBD | |
11:00am-11:30am | Presentation title TBD | STEPHEN HAGGARTY, PhD Associate Professor, Harvard Medical School |
11:30am-12:00pm | Presentation title TBD | YASMIN HURD, PhD Director of the Addiction Institute, Icahn School of Medicine Mount Sinai |
12:00pm-12:20pm | BREAK | |
12:20pm-12:50pm | Therapeutics: The Role of Academia and Industry in Advancing Precision Psychiatry Moderator: TBD | |
12:20pm-12:50pm | Panel | JENNY BARNETT, PhD Chief Executive Officer, Monument Therapeutics
DAVID OLSON, PhD Chief Innovation Officer, Delix Therapeutics
MORGAN SHENG, PhD Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard |
12:50pm-1:50pm | Genomic Medicine Session Chair: TBD | |
12:50pm-1:20pm | Presentation title TBD | WENDY CHUNG, MD, PhD Kennedy Family Professor of Pediatrics and Medicine, Columbia University |
1:20pm-1:50pm | Presentation title TBD | JEHANNINE AUSTIN, PhD, MSc Professor, University of British Columbia |
1:50pm-2:00pm | Closing Remarks | JORDAN W. SMOLLER, MD, ScD |
KEYNOTE SPEAKERS
Thomas Insel, MD - Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022)
Kelsey Martin, PhD - Director of the Simons Foundation Autism Research Initiative (SFARI)
SPEAKERS
Jehannine Austin, PhD - Professor, University of British Columbia
Jennifer Barnett, PhD - Chief Executive Officer, Monument Therapeutics
Chad Bousman, PhD - Associate Professor, University of Calgary
Wendy Chung, MD, PhD - Kennedy Family Professor of Pediatrics and Medicine, Columbia University
Lea Davis, PhD - Assistant Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
Laura Germine, PhD - Director of Brain and Cognitive Health Technology, McLean Hospital
Stephen Haggarty, PhD - Associate Professor, Harvard Medical School Oliver Harrison, MA, MPH - Chief Executive Officer, Koa Health
Yasmin Hurd, PhD - Director of the Addiction Institute, Mount Sinai
Scott Kollins, PhD - Chief Medical Officer, Holmusk
Cathryn Lewis, PhD - Professor of Genetic Epidemiology & Statistics, & Head of Department, Social, Genetic & Developmental Psychiatry Centre, King's College London
David Olson, PhD - Chief Innovation Officer, Delix Therapeutics
Anthony Philippakis, MD, PhD - Chief Data Officer, Broad Institute of MIT and Harvard
Nigam Shah, PhD - Professor of Medicine, Stanford University
Morgan Sheng, PhD - Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Price
COURSE DIRECTORS/PLANNERS
Jordan Smoller, MD, ScD – Director, MGH Center for Precision Psychiatry; Director, MGH Psychiatric and Neurodevelopmental Genetics Unit; Professor of Psychiatry, Harvard Medical School; Professor in Epidemiology, T.H. Chan Harvard School of Public Health
Megan Candito, MA – Marketing and Administrative Coordinator, MGH Center for Precision Psychiatry
Karmel Choi, PhD – Director, Precision Prevention Program at MGH Center for Precision Psychiatry; Clinical Psychologist at MGH; Assistant Professor at Harvard Medical School
Maurizio Fava, MD – Psychiatrist-in-Chief, MGH; Vice Chair, MGH Executive Committee of Research
Roy Perlis, MD - Associate Chief (Research), MGH Department of Psychiatry; Director, MGH Center for Quantitative Health; Director, MGH Center for Experimental Drugs and Diagnostics; Ronald I. Dozoretz, MD Endowed Professor of Psychiatry, Harvard Medical School
Jerrold Rosenbaum, MD – Director, MGH Center for the Neuroscience of Psychedelics; Stanley Cobb Professor of Psychiatry, Harvard Medical School; Co-Founder and Director, Psy Therapeutics, Inc; Co-Founder, Sensorium Therapeutics
Ashley Seiger, MSc – Program Director, MGH Center for Precision Psychiatry
Sabine Wilhelm, PhD – Director, MGH Center for Digital Mental Health; Chief of Psychology, MGH; Director, MGH Center for OCD and Related Disorders; Professor, Harvard Medical School